Rosuvastatin delivery

The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies fibrates or niacin , gemfibrozil, cyclosporine, atazanavir ritonavir, lopinavir ritonavir, or simeprevir see dosage and administration 2 and drug interactions 7 .
Continue reading “Rosuvastatin delivery”